FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shuyu Zhang

Research Profile

Chemicals & Drugs

Disorders

Procedures

Double-Blind Method

Concepts & Ideas

Phenomena

Recurrence

Activities & Behaviors

Questionnaires

Co-author Network

Publications

TOP 3
Lesley M Arnold; Shuyu Zhang; Beth A Pangallo
Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
Vladimir Skljarevski; Shuyu Zhang; Jonna Ahl; Peng Liu; James M Martinez
Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials.
Paula T Trzepacz; Michael M Witte; Shuyu Zhang; Mark E Bangs; Thomas J Spencer; Durisala Desaiah
Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shuyu Zhang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Lesley M Arnold; Shuyu Zhang; Beth A Pangallo
Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
The Clinical journal of pain 2012;28(9):775-81.
2012: Vladimir Skljarevski; Shuyu Zhang; Jonna Ahl; Peng Liu; James M Martinez
Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials.
Pain research and treatment 2012;2012():296710.
2011: Paula T Trzepacz; Michael M Witte; Shuyu Zhang; Mark E Bangs; Thomas J Spencer; Durisala Desaiah
Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial.
Current medical research and opinion 2011;27 Suppl 2():45-52.
2011: Amy S Chappell; Durisala Desaiah; Hong Liu-Seifert; Shuyu Zhang; Vladimir Skljarevski; Yuri Belenkov; Jacques P Brown
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee.
Pain practice : the official journal of World Institute of Pain 2011;11(1):33-41.
2010: Vladimir Skljarevski; Shuyu Zhang; Durisala Desaiah; Karla J Alaka; Santiago Palacios; Tomasz Miazgowski; Kyle Patrick
Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.
The journal of pain : official journal of the American Pain Society 2010;11(12):1282-90.
2010: Vladimir Skljarevski; Shuyu Zhang; Amy S Chappell; Daniel J Walker; Isabelle Murray; Misha-Miroslav Backonja
Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
Pain medicine (Malden, Mass.) 2010;11(5):648-57.
2010: Hong Liu-Seifert; Shuyu Zhang; Deborah D'Souza; Vladimir Skljarevski
A closer look at the baseline-observation-carried-forward (BOCF).
Patient preference and adherence 2010;4():11-6.
2009: Jan K Buitelaar; Timothy E Wilens; Shuyu Zhang; Yu Ning; Peter Feldman
Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo.
Journal of child psychology and psychiatry, and allied disciplines 2009;50(3):335-42.
2008: Paula T Trzepacz; Richard Bourne; Shuyu Zhang
Designing clinical trials for the treatment of delirium.
Journal of psychosomatic research 2008;65(3):299-307.
2008: Mark E Bangs; Sitra Tauscher-Wisniewski; John P Polzer; Shuyu Zhang; Nayan Acharya; Durisala Desaiah; Paula T Trzepacz; Albert J Allen
Meta-analysis of suicide-related behavior events in patients treated with atomoxetine.
Journal of the American Academy of Child and Adolescent Psychiatry 2008;47(2):209-18.
2008: Mark E Bangs; Ling Jin; Shuyu Zhang; Durisala Desaiah; Albert J Allen; Holly A Read; Arie Regev; Joachim F Wernicke
Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder.
Drug safety : an international journal of medical toxicology and drug experience 2008;31(4):345-54.
2007: Joachim F Wernicke; Karen Chilcott Holdridge; Ling Jin; Timothy Edison; Shuyu Zhang; Mark E Bangs; Albert J Allen; Susan Ball; David Dunn
Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.
Developmental medicine and child neurology 2007;49(7):498-502.
2007: John P Polzer; Mark E Bangs; Shuyu Zhang; Mary Anne Dellva; Sitra Tauscher-Wisniewski; Nayan Acharya; Susan B Watson; Albert J Allen; Timothy E Wilens
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD.
Biological psychiatry 2007;61(5):713-9.
2007: Jan K Buitelaar; David Michelson; Marina Danckaerts; Christopher Gillberg; Thomas J Spencer; Alessandro Zuddas; Douglas E Faries; Shuyu Zhang; Joseph Biederman
A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year.
Biological psychiatry 2007;61(5):694-9.
2007: David Michelson; Holly A Read; Dustin D Ruff; Jennifer W Witcher; Shuyu Zhang; James McCracken
CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(2):242-51.
2006: Philip Hazell; Shuyu Zhang; Tomasz Wolańczyk; Joanne Barton; Mats Johnson; Alessandro Zuddas; Marina Danckaerts; Andrula Ladikos; David Benn; Roni Yoran-Hegesh; Pal Zeiner; David Michelson
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
European child & adolescent psychiatry 2006;15(2):105-10.
2006: Jan K Buitelaar; Joanne Barton; Marina Danckaerts; Edgar Friedrichs; Christopher Gillberg; Philip Hazell; Hans Hellemans; Mats Johnson; Luuk J Kalverdijk; Gabriele Masi; David Michelson; Olivier Revol; Javier San Sebastian; Shuyu Zhang; Alessandro Zuddas
A comparison of North American versus non-North American ADHD study populations.
European child & adolescent psychiatry 2006;15(3):177-81.
2004: Jan K Buitelaar; Marina Danckaerts; Christopher Gillberg; Alessandro Zuddas; Katja Becker; Manuel Bouvard; Jenny Fagan; Julia Gadoros; Valerie Harpin; Philip Hazell; Mats Johnson; Tally Lerman-Sagie; Cesar A Soutullo; Tomasz Wolanczyk; Pal Zeiner; Daniel S Fouche; Judith Krikke-Workel; Shuyu Zhang; David Michelson
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD.
European child & adolescent psychiatry 2004;13(4):249-57.
2004: David Michelson; Jan K Buitelaar; Marina Danckaerts; Christopher Gillberg; Thomas J Spencer; Alessandro Zuddas; Douglas E Faries; Shuyu Zhang; Joseph Biederman
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.
Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(7):896-904.
2004: Melissa J Joliat; Mark E Schmidt; Maurizio Fava; Shuyu Zhang; David Michelson; Nancy J Trapp; Cherri M Miner
Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine.
The Journal of clinical psychiatry 2004;65(3):373-8.
2002: Maurizio Fava; Mark E Schmidt; Shuyu Zhang; Jill Gonzales; Nancy J Raute; Rajinder Judge
Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment.
Psychotherapy and psychosomatics 2002;71(4):195-9.
2002: Mark E Schmidt; Maurizio Fava; Shuyu Zhang; Jill Gonzales; Nancy J Raute; Rajinder Judge
Treatment approaches to major depressive disorder relapse. Part 1: dose increase.
Psychotherapy and psychosomatics 2002;71(4):190-4.